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The slow response characteristics of the combined transcutaneous electrode have been viewed as a major
disadvantage when compared with other types of non-invasive assessment of gas exchange during exercise testing.
We have previously shown that by using the highest recommended temperature of 458C to reduce response times,
and combining this with an exercise protocol of gradual work load increments, that this allows changes in arterial
blood gases to be closely followed by transcutaneous values. In the present study we have validated the use of a
transcutaneous electrode for estimation of alveolar–arterial oxygen gradient (AaO2) and dead space to tidal volume
ratio (VD/VT) during exercise, against values calculated from direct arterial blood gas analysis. One hundred
measurements were made in 20 patients with various cardiopulmonary disorders who underwent exercise testing.
Exercise testing was performed by bicycle ergometry with a specific protocol involving gradual work load
increments at 2 min intervals. Transcutaneous gas tensions were measured by a heated combined O2 and CO2
electrode. Arterial blood was sampled at the midpoint of each stage of exercise and transcutaneous tensions noted
at the end of each stage. The mean dierence of the AaO2 gradient calculated from blood gas tensions obtained by
the two methods was 0.14 kPa. The limits of agreement were 7026 and 063 kPa. The same values for VD/VT
calculated from gas tensions measured by the two methods were: mean dierence 0001; limits of agreement
700242 and 00252. For both these parameters there was an even scatter around the mean value on Bland and
Altman analysis. The findings of this study suggest that estimation of parameters of gas exchange using
transcutaneous values during exercise testing is reliable, provided the electrode is heated to a slightly higher
temperature than usual and the work load increments are gradual, allowing for the latency in the response time of
the system. This system allows the assessment of the contribution of ventilation/perfusion inequality to
breathlessness on exertion in patients, provided an initial arterial or ear lobe capillary sample is obtained for
calibration purposes. This technique is particularly valuable in patients undergoing repeat exercise tests as it
circumvents the need for arterial cannulation.
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It has been suggested that the slow response characteristics
of transcutaneous electrodes would render them unsuitable
for use during exercise testing. An electrode temperature of
approximately 438C is required to maintain adequate skin
perfusion (1) but even at these temperatures the oxygen
electrode, with its recording delay during the warm-up
period and slow response times, has been demonstrated to
miss rapid changes in arterial PO2(2–4). Several previous
studies, however, have demonstrated that the transcuta-
neous oxygen electrode provides a reliable method ofReceived 9 June 1999 and accepted in revised form 28 September
1999.
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0954-6111/00/040350+06 $35?00/0continuously monitoring the changes in arterial oxygen
tension in adults undergoing exercise tests (5–8) but
diculties were encountered in other studies (9).
More controversy surrounds the use of the transcuta-
neous carbon dioxide electrode to monitor arterial carbon
dioxide tensions during exercise testing. It has been shown
that tcPCO2 reflects arterial PCO2 in haemodynamically
stable patients at rest using an electrode temperature of
39–408C (10–12). At this temperature, however, there is a
slow response time for monitoring changes which, in some
cases, was as long as 3 min thus precluding its use in
exercise testing (13). The use of a higher electrode
temperature produces a systematically higher skin surface
carbon dioxide tension and, in addition, a more rapid
response time (14,15). In our own laboratory the use of an
electrode temperature of 458C produces response times of
the tcPO2 and tcPCO2 electrode to a change in breath
pattern or inspired gas of 30 and 55 sec, respectively (16,17).
In addition, we have assessed the combined transcutaneous# 2000 HARCOURT PUBLISHERS LTD
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arterial sampling during exercise testing. This study showed
that by using the highest recommended temperature of
458C to reduce response times, and combining this with an
exercise protocol of gradual work load increments of 2 min
periods, this allows changes in arterial blood gases to be
closely followed by transcutaneous values (18).
The accurate non-invasive assessment of arterial gas
tensions has important implications during cardiopulmon-
ary exercise testing since, with the measurement of mixed
expired gases and minute ventilation, this allows the
calculation of sensitive indices of ventilation/perfusion
inequality at all stages during the exercise test.
The good agreement between arterial and transcutaneous
values of oxygen and carbon dioxide during exercise testing
following an in vivo calibration allows the calculation of
these standard indices of ventilation/perfusion inequality
from these non-invasive measurements. This would allow
the assessment of the contribution of these indices to
exertional breathlessness with circumvention of the need for
arterial cannulation. We have therefore validated the use of
the combined transcutaneous electrode for the estimation
of the alveolar–arterial oxygen dierence (AaO2 ) and dead
space to tidal volume ratio (VD/VT) during exercise testing
against values calculated from direct arterial blood gas
analysis.
PATIENTS
Full exercise and blood gas data was available for 14
patients (10 men, four women) from our original study who
were referred from respiratory or general medical clinics for
a symptom limited progressive exercise test. The group
comprised patients with a range of cardiopulmonary
disorders of varying degrees of severity, and also included
patients with unexplained breathlessness. A further six
patients were referred from the Scottish Cardiopulmonary
Transplant Unit who had progressive cardiopulmonary
exercise testing with full gas exchange as part of their
assessment for cardiac transplantation. Informed consent
was obtained from the patients prior to the exercise tests.
Ethical committee approval had been granted for the
original study from which this data is derived and for the
cardiac transplant patients for a cardiopulmonary exercise
test with full gas exchange as part of their routine
assessment for consideration of transplantation.
The characteristics of these patients are shown in Table 1.
Methods
The AaO2 gradient and VD/VT were calculated using
standard formulae (19) described below at rest and during
a progressive cardiopulmonary exercise test.
The AaO2 gradient is calculated from the alveolar gas
equation:
PAO2  PIO2 ÿ PaCO2
R
ÿ FIO2:PaCO2:1ÿ R=Rwhere PIO2 is the inspired oxygen tension; PaCO2 is the
arterial (transcutaneous) carbon dioxide tension; FIO2 is the
fractional concentration of oxygen in the inspired air; and
R is the respiratory exchange ratio.
The respiratory exchange ratio (R) is the volume of
carbon dioxide evolved divided by the volume of oxygen
consumed; it was calculated from the following formula:
R  PECO2=PIO2:PEN2=PIN2 ÿ PEO2
Where PI denotes the partial pressure in the inspired gas
mixture and PE denotes the partial pressure in the mixed
expired gas mixture.
The transcutaneous or arterial oxygen tension was
subtracted from the calculated alveolar oxygen tension to
produce the gradient at rest and at each work load
increment.
The dead space/tidal volume ration was calculated from
the following formula:
VD=VT  PaCO2 ÿ PECO2=PaCO2
where Pa denotes arterial (transcutaneous) partial pressure
and PE denotes the partial pressure in the mixed expired gas
mixture.
The combined transcutaneous electode ( TCM3, Radio-
meter, Copenhagen, Denmark) was initially calibrated in
vitro at two points; the first calibration gas contained 5%
carbon dioxide and 209% oxygen and the second 10%
carbon dioxide in nitrogen. The electrode temperature was
set to 458C. The combined sensor was then attached to the
skin of the upper quadrant of the chest with an adhesive
ring after a drop of contact fluid was placed in the ring. The
TCM3 monitor automatically corrects the tcPCO2 output
back to 378C according to the Siggaard–Andersen equation
(14). After the output of the TCM3 monitor was stable
(approximately 10 min) an arterial sample was obtained
from a previously inserted arterial cannula. These samples
were analysed immediately for oxygen and carbon dioxide
tensions using an ABL5 blood gas analyser (Radiometer,
Copenhagen, Denmark). The gain controls of the TCM3
monitor were then altered so that the output of the tcPO2
and tcPCO2 corresponded to the measured PaO2 and
PaCO2 (in vivo calibration).
Symptom limited exercise tests were performed using an
electrically braked bicycle ergometer, with the patient
breathing through a low dead space, low resistance valve
box (Benchmark exercise test system, Morgan Medical,
Kent England). The valve box contains a flexible pneumo-
tachograph for the calculation of inspired and expired flows
which are integrated to calculate minute ventilation. The
expired limb is fed through a mixing chamber from which
mixed expired gas concentrations can be analysed for
carbon dioxide (infra-red gas analyser) and oxygen (fuel cell
reference and rapidly responding zirconium analyser)
The averaged mixed expired concentrations of oxygen
and carbon dioxide and minute ventilation over the last
30 sec of a 2 min resting period were used to calculate the
respiratory exchange ratio by the formula described above.
An arterial blood sample was obtained from a previously
inserted arterial cannula during the middle period of the
resting phase and the values of PaCO2 and PaO2 measured
VD/VT calculated from direct arterial sampling and from
transcutaneous PCO2 measurements derived from 100
simultaneous measurements (r=099, P50001). The va-
lues for VD/VT calculated from gas tensions measured by
the two methods (Fig. 4) gave a mean dierence of 0001
(limits of agreement 00252 and 700242) with an even
scatter around the mean value.
TABLE 1. Characteristics of the study population
Diagnosis n Age range (years) Sex Summary of cardiorespiratory function
Unexplained breathlessness 2 29 and 54 2M Normal cardiorespiratory function
Chronic obstructive pulmonary
disease (COPD)
8 57–67 6M, 2F Mean FEV1 45% predicted (range 36–66%)
Pulmonary thromboembolic disease 2 31 and 45 2F Angiographically proven pulmonary thrombo-
embolism. Normal lung volumes reduced TLCO
Hyperventilation syndrome 2 27 and 45 2M Normal FEV1, TLCO
Normal ECG
Ischaemic heart disease 4 53–64 3M, 1F ECG and coronary angiography evidence
of IHD; on active treatment.
Transplant assessments
Cardiomyopathy 2 38 and 41 2M Normal lung volumes, no airflow
obstruction, reduced TLCO.
Transplant assessments
FIG. 1. AaO2 gradient: transcutaneous against direct
arterial sampling. y=09905x +00226; R2=09977.
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tcPCO2 values were noted at the end of the resting period to
take account of the previously measured lag and response
time of the transcutaneous electrode. The arterial and
transcutaneous values obtained, together with the mixed
expired concentrations of oxygen and carbon dioxide, were
used to calculate resting values of AaO2 gradient and VD/VT
using the standard equations previously described. A
progressive exercise test was then performed in 20 patients
with various cardiopulmonary disorders on an electrically
braked bicycle ergometer with a specific protocol involving
gradual work load increments (10–25 watts) at 2 min
intervals until symptomatic limitation of exercise. The AaO2
gradient and VD/VT were calculated for each work load
increment as described above using both the arterial and
transcutaneous oxygen and carbon dioxide tensions. The
measurement of the indices of ventilation/perfusion in-
equality obtained by arterial and transcutaneous monitor-
ing were compared by regression analysis and the analysis
of Bland and Altmann (20).
Results
In this study the range of arterial PO2 and PCO2 measured
was 60–140 kPa and 35–70 kPa respectively. The 20
patients investigated produced 100 measurements of gas
exchange indices during cardio-pulmonary exercise testing.
In these 20 patients the AaO2 gradient calculated using
direct arterial oxygen tension ranged from 09–96 kPa.
There was a significant correlation (Fig. 1) between the
AaO2 calculated from direct arterial sampling and from
transcutaneous PO2 measurements derived from these 100
simultaneous measurements (r=098, P5 0001). The mean
dierence of the AaO2 calculated from blood gas tensions
obtained by the two methods was 0.14 kPa (limits of
agreement 7026 and 063 kPa) with an even scatter
around the mean value (Fig. 2). The VD/VT calculated from
arterial carbon dioxide tension ranged from 015–064.
There was a significant correlation (Fig. 3) between theDiscussion
The slow response characteristics of the combined transcu-
taneous electrode has been viewed as a major disadvantage
FIG. 2. Bland and Altman analysis: AaO2 gradient—
transcutaneous against direct arterial sampling.
FIG. 3. VD/VT: transcutaneous against direct arterial
blood sampling. y=09956x +00009; R2=09954.
FIG. 4. Bland and Altman analysis: VD/VT—
transcutaneous against direct arterial sampling.
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ment of gas exchange during exercise testing using pulse
oximetry (21) or end tidal measurement of carbon dioxide
(22). Some of these diculties may have been caused by the
dierent temperature settings used with the transcutaneous
electrode (42–448C) producing a range of response times.
Furthermore, the transcutaneous system may have been
calibrated using a dry gas mixture, or an in vivo calibration
may have depended on a single arterial stab prior to theexercise tests. The present study has shown that indices of
gas exchange measured by transcutaneous monitoring
closely follows those assessed by direct arterial sampling
during cardiopulmonary exercise testing.
The response time of the transcutaneous oxygen elec-
trode has previously been assessed in a study by Schonfield
et al. (6). This group reported a 90% response time for
tcPO2, with an electrode temperature of 428C, after a step
change in inspired oxygen concentration to be 1825 
79 sec during exercise which would preclude the use of
transcutaneous monitoring during rapidly progressive
exercise protocols. However, using a higher electrode
temperature of 458C, Gray et al., in a comparison with
pulse oximetry, showed that both transcutaneous and ear
oximeter responded to changes in inspired oxygen sig-
nificantly more slowly than end-tidal measurements, but
that during exercise there was no significant dierence
between the response characteristics of the ear oximeter and
tcPO2 electrode (8). This study showed a 90% response
time of 25–30 sec for the transcutaneous oxygen monitor
which would make it suitable for monitoring arterial PO2
during exercise testing. These findings were confirmed in
our own laboratory: using an electrode temperature of
458C, the tcPO2 electrode responded to changes in breath-
ing pattern, inspired gas or changes on exercise testing in
30 sec (16,17).
With the use of a combined electrode, higher electrode
temperatures produce an increase in the temperature of
capillary blood which leads to a systematically higher skin
surface carbon dioxide tension than when measured at 378C
although a temperature correction can be applied (14). In
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response time so that using an electrode temperature of
448C, Nickerson et al. (15) showed a lag time of 302 sec
and a 50% response time to changes in carbon dioxide of
332 sec during vigorous exercise. They concluded that
changes in ventilation will not be reflected by the CO2
electrode for at least 1 min. This was again confirmed by
our previous studies which showed that using an electrode
temperature of 458C, with a temperature correction
applied, changes in carbon dioxide tension would be
reflected at 55 sec (16,17). The combination of the
transcutanoeous electrode at its highest temperature setting
and the use of a progressive exercise test incorporating
gradual work load increments of 2 min, therefore, allows
arterial blood gases to be monitored by transcutaneous
values during cardiopulmonary exercise testing (18).
Full gas exchange assessment during progressive exercise
testing has previously relied upon the insertion of an
arterial line (23) which may be associated with significant
complications (24). The validation of the transcutaneous
method against directly measured arterial oxygen and
carbon dioxide tensions during an exercise test has led to
the possibility of non-invasive, apart from a single arterial
blood sample (arterialized earlobe capillary sample),
monitoring of indices of gas exchange during exercise
testing. The indices of alveolar–arterial oxygen gradient
and dead space/tidal volume ratio are more specific
indicators of the function of the pulmonary gas exchange
mechanism and are important determinants of the ventila-
tory requirement on exertion (25). An increase in the ratio
of dead space to tidal volume (VD/VT) ratio, for example,
compromises the eectiveness of the ventilatory capacity in
maintaining adequate alveolar ventilation on exertion and
in this way contributes to breathlessness. An additional
stimulus to ventilation is the development of arterial
hypoxaemia during graded exercise. This results in a
widening alveolar–arterial oxygen gradient (AaO2) which
is one of the best indicators of pulmonary gas exchange
abnormalities. An increased ventilatory requirement on
exertion may, therefore, be a contributory factor to
exertional dyspnoea in patients with cardiac or pulmonary
disease (25–31). The use of the transcutaneous electrode
during cardiopulmonary exercise testing in our laboratory
has allowed assessment of the contribution of gas exchange
abnormality, without arterial cannulation, to aerobic
capacity in patients with ankylosing spondylitis (32).
Currently this method is being used to assess the contribu-
tion of gas exchange abnormality to the ventilatory
response on exertion in patients with COPD prior to and
following a programme of pulmonary rehabilitation with
nutritional supplementation. In addition this method is
being used to assess the eects of cardiac transplantation on
the raised ventilatory response to exertion in patients with
cardiac failure (33).
In conclusion, this study suggests that a combined tcPO2
and tcPCO2 electrode can be used to provide a reliable non-
invasive estimate of indices of gas exchange on exercise
testing provided the maximal permissible temperature is
selected, together with gradual work load increments at 2
min intervals. The technique circumvents the need forarterial cannulation, but requires an initial in vivo calibra-
tion using a single arterial puncture or arterialized ear-lobe
capillary sample (34) for accurate monitoring of arterial
blood gas values during exercise. The system allows the
non-invasive, apart from this single arterial puncture,
assessment of the contribution of ventilation/perfusion
inequality to breathlessness on exertion in patients and is,
therefore, particularly valuable in patients undergoing
repeat exercise tests.
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